# Clustering Approach 1 : CN_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.885908449727579	Range of duration = 0.03 to 357.37, nDeath = 92, nCensor = 100
2	AGE	ANOVA	0.403272020030465	Range of values = 18 to 90, Mean = 56.7626, StdDev = 16.0933, nMissing = 4
3	PRIMARY.SITE.OF.DISEASE	Chi-square test	0.65551610856696	nTypes = 4 (DISTANT METASTASIS/PRIMARY TUMOR/REGIONAL CUTANEOUS OR SUBCUTANEOUS TISSUE (INCLUDES SATELLITE AND IN-TRANSIT METASTASIS)/REGIONAL LYMPH NODE), nPatients = 27/26/37/112
4	GENDER	Fisher's exact test	0.858242798864287	nTypes = 2 (FEMALE/MALE), nPatients = 76/126
5	RADIATIONS.RADIATION.REGIMENINDICATION	Fisher's exact test	0.0595278557706631	nTypes = 2 (NO/YES), nPatients = 3/199
6	DISTANT.METASTASIS	Chi-square test	0.602884336464959	nTypes = 5 (M0/M1/M1A/M1B/M1C), nPatients = 176/2/2/2/3, nMissing = 17
7	LYMPH.NODE.METASTASIS	Chi-square test	0.253349678220674	nTypes = 10 (N0/N1/N1A/N1B/N2/N2A/N2B/N2C/N3/NX), nPatients = 110/2/8/17/1/5/14/6/19/5, nMissing = 15
8	TUMOR.STAGECODE	ANOVA	NA	Range of values = Inf to -Inf, Mean = NaN, StdDev = NA, nMissing = 202
9	NEOPLASM.DISEASESTAGE	Chi-square test	0.703975287712438	nTypes = 13 (I OR II NOS/STAGE I/STAGE IA/STAGE IB/STAGE II/STAGE IIA/STAGE IIB/STAGE IIC/STAGE III/STAGE IIIA/STAGE IIIB/STAGE IIIC/STAGE IV), nPatients = 4/17/10/15/20/9/10/23/9/7/21/27/7, nMissing = 23